Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 38% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -85.8%
- Revenue declining 100% annually
PALATIN TECHNOLOGIES, INC. (PTN) is a Healthcare company operating in Pharmaceutical Preparations, listed on the AMEX , with a market capitalisation of $38 million . Key value metrics: P/E ratio 13.0, P/B ratio 3.32, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
PALATIN TECHNOLOGIES, INC. — Fundamental Analysis Summary
PALATIN TECHNOLOGIES, INC. (PTN) is currently trading 38% above its Graham Number of $15.50, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 13.0x.
On financial health, PTN shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -85.8% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.56.
StockPik's composite Value Score for PTN is 42/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PTN reports a high gross margin of 98.9% (sector average: 33.5%) and a negative operating margin of -112.6%.
PTN shows revenue declining at 100% year-over-year, with earnings growing at 42%.